Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 3
1989 35
1990 119
1991 136
1992 104
1993 108
1994 73
1995 71
1996 83
1997 59
1998 73
1999 49
2000 54
2001 38
2002 55
2003 44
2004 58
2005 46
2006 67
2007 61
2008 62
2009 51
2010 43
2011 46
2012 33
2013 36
2014 34
2015 27
2016 20
2017 18
2018 18
2019 10
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

1,669 results
Results by year
Filters applied: . Clear all
Page 1
Selective use of primate CD4 receptors by HIV-1.
Warren CJ, Meyerson NR, Dirasantha O, Feldman ER, Wilkerson GK, Sawyer SL. Warren CJ, et al. PLoS Biol. 2019 Jun 10;17(6):e3000304. doi: 10.1371/journal.pbio.3000304. eCollection 2019 Jun. PLoS Biol. 2019. PMID: 31181085 Free PMC article.
Pathological Role of Anti-CD4 Antibodies in HIV-Infected Immunologic Nonresponders Receiving Virus-Suppressive Antiretroviral Therapy.
Luo Z, Li Z, Martin L, Wan Z, Meissner EG, Espinosa E, Wu H, Yu X, Fu P, Julia Westerink MA, Kilby JM, Wu J, Huang L, Heath SL, Li Z, Jiang W. Luo Z, et al. J Infect Dis. 2017 Jul 1;216(1):82-91. doi: 10.1093/infdis/jix223. J Infect Dis. 2017. PMID: 28498953 Free PMC article.
Understanding the CD4 molecule: surface expression and function.
Morrison WJ, Offner H, Vandenbark AA. Morrison WJ, et al. J Neurosci Res. 1994 May 1;38(1):1-5. doi: 10.1002/jnr.490380102. J Neurosci Res. 1994. PMID: 8057386 Review.
Therapeutic applications of anti-CD4 antibodies.
Olive D, Mawas C. Olive D, et al. Crit Rev Ther Drug Carrier Syst. 1993;10(1):29-63. Crit Rev Ther Drug Carrier Syst. 1993. PMID: 8472311 Review.
CD4-gp120 interactions.
McDougal JS, Klatzmann DR, Maddon PJ. McDougal JS, et al. Curr Opin Immunol. 1991 Aug;3(4):552-8. doi: 10.1016/0952-7915(91)90020-2. Curr Opin Immunol. 1991. PMID: 1721822 Review.
CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritis.
Mason U, Aldrich J, Breedveld F, Davis CB, Elliott M, Jackson M, Jorgensen C, Keystone E, Levy R, Tesser J, Totoritis M, Truneh A, Weisman M, Wiesenhutter C, Yocum D, Zhu J. Mason U, et al. J Rheumatol. 2002 Feb;29(2):220-9. J Rheumatol. 2002. PMID: 11838838 Clinical Trial.
1,669 results
Jump to page
Feedback